REFERENCES
- Provisor A J, Ettinger L J, Nachman J B, et al. Treatment of nonmetastatic osteosarcoma of the extremity with the preoperative and postoperative chemotherapy: a report from the Children's Cancer Group. J Clin Oncol 1997; 15: 76–84, [PUBMED], [INFOTRIEVE]
- Bacci G, Picci P, Ruggieri P, et al. Primary chemotherapy and delayed surgery (neoadjuvant chemotherapy) for osteosarcoma of the extremities: the Instituto Rizzoli Experience in 127 patients treated preoperatively with intravenous methotrexate (high versus moderate doses) and intraarterial cisplatin. Cancer 1990; 65: 2539–2553, [PUBMED], [INFOTRIEVE]
- Postovsky S, Elhasid R, Ben-Barak A, et al. Allergic reaction to high-dose methotrexate. Med Pediatr Oncol 2000; 35: 131–132, [PUBMED], [INFOTRIEVE]
- Huvos A G, Rosen G, Marcove R C. Primary osteogenic sarcoma: pathologic aspects in 20 patients after treatment with chemotherapy, en block resection, and prosthetic bone replacement. Arch Pathol Lab Med 1977; 101: 14–18, [PUBMED], [INFOTRIEVE]
- Baack B R, Burgdorf WHC. Chemotherapy-induced acral erythema. J Am Acad Dermatol 1991; 24: 457–461, [PUBMED], [INFOTRIEVE]
- Nagore E, Insa A, Sanmartin O. Antineoplastic therapy-induced palmar plantar erythrodysesthesia (‘hand-foot’) syndrome: incidence, recognition and management. Am J Clin Dermatol 2000; 1: 225–234, [PUBMED], [INFOTRIEVE], [CSA]
- Komamura H, Higashiyama M, Hashimoto K, et al. Three cases of chemotherapy-induced acral . J Dermatol 1995; 22: 116–121, [PUBMED], [INFOTRIEVE]
- Kroll S S, Koller C A, Kaled S, Dreizen S. Chemotherapy-induced acral erythema: desquamating involving the hands and feet. Ann Plast Surg 1989; 23: 263–265, [PUBMED], [INFOTRIEVE]
- Azurdia R M, Clark R E, Friedmann P S. Chemotherapy-induced acral erythema (CIAE) with bullous reaction. Clin Exp Dermatol 1999; 24: 64–66, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Cohen P R. Acral erythema: a clinical review. Cutis 1993; 51: 175–179, [PUBMED], [INFOTRIEVE]
- Millot F, Auriol F, Brecheteau P, Guilhot F. Acral erythema in children receiving high-dose methotrexate. Pediatr Dermatol 1999; 16: 398–400, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Ikeda H, Kawano H, Kitaura T, et al. Acral erythema associated with high-dose methotrexate infusion. Ann Pharmacother 1999; 33: 646, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Hellier I, Bessis D, Sotto A, et al. High-dose methotrexate-induced bullous variant of acral erythema. Arch Dermatol 1996; 132: 590–591, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Demircay Z, Gurbuz O, Alpdogan T B, et al. Chemotherapy-induced acral erythema in leukemic patients: a report of 15 cases. Int J Dermatol 1997; 36: 593–598, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Shall L, Lucas G S, Whittaker J A, Holt P J. Painful red hands: a side-effect of leukaemia therapy. Br J Dermatol 1988; 119: 249–253, [PUBMED], [INFOTRIEVE]
- Ogawa H, Sugiyama H, Tani Y, et al. High incidence of chemotherapy-induced acral erythema in female patients with non-Hodgkin's lymphoma treated with the VACOP-B regimen. Leuk Lymphoma 1998; 29: 171–177, [PUBMED], [INFOTRIEVE], [CSA]
- Kampmann K K, Graves T, Rogers S D. Acral erythema secondary to high-dose cytosine arabinoside with pain worsened by cyclosporine infusions. Cancer 1989; 63: 2482–2485, [PUBMED], [INFOTRIEVE]
- Cox G J, Robertson D B. Toxic erythema of palms and soles associated with high-dose mercaptopurine chemotherapy. Arch Dermatol 1986; 122: 1413–1414, [PUBMED], [INFOTRIEVE], [CROSSREF]
- de Argila D, Dominguez J D, Iglesias L. Taxol-induced acral erythema. Dermatology 1996; 192: 377–378, [PUBMED], [INFOTRIEVE]
- Vakalis D, Ioannides D, Lazaridou E, et al. Acral erythema induced by chemotherapy with cisplatin. Br J Dermatol 1998; 139: 750–751, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Reynaert H, De Coninck A, Neven A M, et al. Chemotherapy-induced acral erythema and acute graft-versus-host disease after allogeneic bone marrow transplantation. Bone Marrow Transplant 1992; 10: 185–187, [PUBMED], [INFOTRIEVE]